Cart
sales@molnova.com
Flecainide hydrochloride
CAS No. 57415-44-8
Flecainide hydrochloride ( —— )
Catalog No. M22227 CAS No. 57415-44-8
Flecainide is a medication used to prevent and treat abnormally fast heart rates.?This includes ventricular and supraventricular tachycardias.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 67 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 205 | Get Quote |
|
| 50MG | 309 | Get Quote |
|
| 100MG | 447 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFlecainide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionFlecainide is a medication used to prevent and treat abnormally fast heart rates.?This includes ventricular and supraventricular tachycardias.
-
DescriptionFlecainide is a medication used to prevent and treat abnormally fast heart rates.?This includes ventricular and supraventricular tachycardias.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number57415-44-8
-
Formula Weight450.8
-
Molecular FormulaC17H21ClF6N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[F]C([F])([F])COc1ccc(OCC([F])([F])[F])c(c1)C(=O)NC[C@@]2([H])CCCCN2.[Cl]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Markey, Gerard, C, et al. INTRAVENOUS FLECAINIDE FOR EMERGENCY DEPARTMENT MANAGEMENT OF ACUTE ATRIAL FIBRILLATION[J]. Journal of Emergency Medicine, 2018.
molnova catalog
related products
-
Stigmastadienone
Stigmastadienone is a natural product.
-
4-[(E)-{[4,6-Di(4-mo...
4-[(E)-{[4,6-Di(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazono}methy l]-2,6-dimethoxyphenol is a chemical compound.
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
